Jennison Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.7M | Sell |
129,980
-2,484
| -2% | -$886K | 0.03% | 233 |
|
|
2025
Q4 | $43.4M | Sell |
132,464
-91,343
| -41% | -$29M | 0.03% | 234 |
|
|
2025
Q3 | $63.2M | Sell |
223,807
-380,967
| -63% | -$110M | 0.04% | 183 |
|
|
2025
Q2 | $169M | Buy |
604,774
+431,036
| +248% | +$122M | 0.1% | 88 |
|
|
2025
Q1 | $54.1M | Sell |
173,738
-17,682
| -9% | -$5.22M | 0.04% | 208 |
|
|
2024
Q4 | $49.9M | Sell |
191,420
-388,045
| -67% | -$115M | 0.03% | 231 |
|
|
2024
Q3 | $187M | Sell |
579,465
-78,759
| -12% | -$25.8M | 0.12% | 83 |
|
|
2024
Q2 | $206M | Buy |
658,224
+105,710
| +19% | +$31.1M | 0.13% | 76 |
|
|
2024
Q1 | $157M | Sell |
552,514
-98,123
| -15% | -$28.7M | 0.11% | 80 |
|
|
2023
Q4 | $187M | Buy |
650,637
+432,871
| +199% | +$118M | 0.14% | 70 |
|
|
2023
Q3 | $58.5M | Buy |
217,766
+95,027
| +77% | +$23.7M | 0.05% | 158 |
|
|
2023
Q2 | $27.3M | Sell |
122,739
-209,687
| -63% | -$48.7M | 0.02% | 280 |
|
|
2023
Q1 | $80.4M | Buy |
332,426
+6,768
| +2% | +$1.66M | 0.07% | 128 |
|
|
2022
Q4 | $85.5M | Buy |
325,658
+154,786
| +91% | +$41.5M | 0.09% | 127 |
|
|
2022
Q3 | $38.5M | Buy |
170,872
+3,292
| +2% | +$798K | 0.04% | 213 |
|
|
2022
Q2 | $40.8M | Buy |
+167,580
| New | +$41.1M | 0.04% | 201 |
|
|
2021
Q3 | – | Sell |
-6,357
| Closed | -$1.55M | – | 666 |
|
|
2021
Q2 | $1.55M | Buy |
6,357
+603
| +10% | +$148K | ﹤0.01% | 583 |
|
|
2021
Q1 | $1.43M | Buy |
+5,754
| New | +$1.37M | ﹤0.01% | 578 |
|
|
2020
Q4 | – | Sell |
-21,567
| Closed | -$5.48M | – | 642 |
|
|
2020
Q3 | $5.48M | Buy |
21,567
+15,921
| +282% | +$3.94M | ﹤0.01% | 426 |
|
|
2020
Q2 | $1.33M | Sell |
5,646
-4,188
| -43% | -$956K | ﹤0.01% | 505 |
|
|
2020
Q1 | $1.99M | Sell |
9,834
-5,467
| -36% | -$1.19M | ﹤0.01% | 441 |
|
|
2019
Q4 | $3.69M | Buy |
15,301
+1,858
| +14% | +$410K | ﹤0.01% | 454 |
|
|
2019
Q3 | $2.6M | Sell |
13,443
-6,373
| -32% | -$1.22M | ﹤0.01% | 482 |
|
|
2019
Q2 | $3.65M | Sell |
19,816
-470
| -2% | -$84.2K | ﹤0.01% | 485 |
|
|
2019
Q1 | $3.85M | Buy |
+20,286
| New | +$3.87M | ﹤0.01% | 475 |
|
|
2018
Q1 | – | Sell |
-74,421
| Closed | -$12.9M | – | 655 |
|
|
2017
Q4 | $12.9M | Sell |
74,421
-115,330
| -61% | -$20.4M | 0.01% | 447 |
|
|
2017
Q3 | $35.4M | Buy |
+189,751
| New | +$33.6M | 0.04% | 318 |
|
|
2017
Q2 | – | Sell |
-1,702
| Closed | -$279K | – | 639 |
|
|
2017
Q1 | $279K | Sell |
1,702
-33,365
| -95% | -$5.54M | ﹤0.01% | 632 |
|
|
2016
Q4 | $5.13M | Buy |
+35,067
| New | +$5.28M | 0.01% | 513 |
|
|
2016
Q3 | – | Sell |
-13,107
| Closed | -$1.99M | – | 651 |
|
|
2016
Q2 | $1.99M | Buy |
+13,107
| New | +$2.04M | ﹤0.01% | 538 |
|
|
2016
Q1 | – | Sell |
-2,448
| Closed | -$397K | – | 610 |
|
|
2015
Q4 | $397K | Buy |
+2,448
| New | +$385K | ﹤0.01% | 635 |
|
|
2015
Q3 | – | Sell |
-23,445
| Closed | -$3.6M | – | 726 |
|
|
2015
Q2 | $3.6M | Buy |
23,445
+11,511
| +96% | +$1.84M | ﹤0.01% | 562 |
|
|
2015
Q1 | $1.91M | Sell |
11,934
-4,857
| -29% | -$765K | ﹤0.01% | 614 |
|
|
2014
Q4 | $2.67M | Buy |
+16,791
| New | +$2.62M | ﹤0.01% | 555 |
|
|
2014
Q3 | – | Sell |
-25,598
| Closed | -$3.03M | – | 720 |
|
|
2014
Q2 | $3.03M | Sell |
25,598
-2,561
| -9% | -$296K | ﹤0.01% | 539 |
|
|
2014
Q1 | $3.47M | Sell |
28,159
-20
| -0.1% | -$2.43K | ﹤0.01% | 542 |
|
|
2013
Q4 | $3.22M | Sell |
28,179
-284,144
| -91% | -$32.3M | ﹤0.01% | 531 |
|
|
2013
Q3 | $35M | Buy |
+312,323
| New | +$33.9M | 0.04% | 368 |
|
Other funds holding AMGN
VCM
VPM
Jennison Associates's AMGN Position: Q1 2026 in Review
Jennison Associates reduced its Amgen (AMGN) stake by 1.9% in Q1 2026, selling an estimated $886K and leaving 129,980 shares worth $45.7M. The position accounts for 0.03% of the portfolio, ranked #233.
Jennison Associates first reported a position in AMGN in Q3 2013 and has held it in 38 quarters since. The position peaked at $206M in Q2 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Jennison Associates held 129,980 shares of Amgen worth $45.7M as of Q1 2026.
- Jennison Associates sold 2,484 Amgen shares in Q1 2026, an estimated $886K.
- Amgen made up 0.03% of Jennison Associates's portfolio in Q1 2026, its #233 holding.
- Jennison Associates first reported a position in Amgen in Q3 2013 and has held it in 38 quarters since.
- Jennison Associates's Amgen position peaked at $206M in Q2 2024.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.